Sequel MED Tech
Clinical Diabetes Specialist- New Orleans
New Orleans, Louisiana
Sponsorship not specified$141k-$161kDetected 12 days ago
RESTData AnalysisMedical DevicesResearchLeadershipCommunicationProblem SolvingMentoring
About the role
- In partnership with the TBL, you will formulate territory strategies and initiatives to meet/exceed territory goals.
- New Orleans, Covington, Slidell As a Senior Clinical Diabetes Specialist, you will additionally take on a leadership role within the team by mentoring junior staff, assisting with field sales training, and participating on internal advisory boards
- Job Responsibilities and Essential Duties
Responsibilities
- As needed, lead weekly team calls, regional and/or area calls and/or meetings.
- As a Clinical Diabetes Specialist (CDS) you will partner with a Territory Business Leader (TBL) to successfully launch a new innovative insulin pump and future Sequel products.
- Develop effective territory planning and strategies with TBL to meet/exceed territory goals.
- Collaborate with customer care and sales support to optimize the user experience.
Requirements
- Required Knowledge, Skills and Abilities:
- Knowledge of diabetes products and therapies.
Nice to have
- RN, RD, PA, NP, Pharmacist.
Skills
- Demonstrated history of high performance in previous roles.
Compensation
- $141k-$161k
Benefits
- Your primary responsibility is to deliver unparalleled clinical education and product training for people with diabetes and healthcare providers to drive product adoption and support persistent use.
- Drive healthcare provider adoption and confidence in Sequel products by promoting the clinical benefits of automated insulin delivery with Sequel products and conducting impactful product demonstrations.
Company info
- About Sequel Sequel, headquartered in Manchester, New Hampshire, is a company developing the next generation of transformative drug-delivery advancements starting with diabetes.
- Sequel's approach is to look at diabetes management holistically to advance systems that make living with diabetes simpler and easier for all.
- Sequel's flagship product, the twiist Automated Insulin Delivery (AID) System, launched in July 2025 for people with type 1 diabetes providing them with personalized diabetes management.
Apply directly at Sequel MED Tech →Create a free account for alerts like thisView Sequel MED Tech immigration profile
This listing is sourced directly from Sequel MED Tech's careers page and normalized into a canonical job model.